Medical Health & Life Science Research News

Research delivers insight into the global injectable drug delivery market

Research delivers insight into the global injectable drug delivery market

Global Injectable Drug Delivery Marketis expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

- Advertising -

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration  (Skin, Circulatory, Organs, Central Nervous System), End User  (Hospitals & Clinics, Home Care Settings, Research Laboratories,  Pharma& Biotech Companies), Geography (North America,  Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024.

The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes.

- Advertising -

On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.

Report:  databridgemarketresearch.com/reque…g-delivery-market Global Injectable Drug Delivery Market Key Drivers:

  • Needlestick injuries and infections, regulatory hurdles, and preference for alternate modes of drug delivery are the factors which may hinder the growth of this market.
  • Many companies are increasingly focusing on biologics and self-injection devices in order to strengthen their product portfolios in the injectable drug delivery market.
  • Development of self-injection devices is changing the trend for the administration of injections in the healthcare sector.
  • Increasing demand for biosimilars and generic injectables will drive the market in future.

Report: databridgemarketresearch.com/speak…g-delivery-market Global Injectable Drug Delivery Market Segmentation:

The Global Injectable Drug Delivery Market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography. The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.In 2017, the injectable drug delivery formulation segment is expected to dominate the market with a share of ~75.0% and is expected to continue this trend till 2024.

Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

Report: databridgemarketresearch.com/repor…-delivery-market/

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.

Read more about the Global Injectable Drug Delivery Market :databridgemarketresearch.com/repor…-delivery-market/

 

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...